CANM endorsement of densitometry guidelines
CJM O'Brien - CMAJ, 2003 - Can Med Assoc
Iappreciated CMAJ's recent editorial on drug marketing, 1 but I wish to highlight here a major
medical education issue that is usually overlooked, in part because of the influence wielded …
medical education issue that is usually overlooked, in part because of the influence wielded …
[PDF][PDF] Drug marketing priorities
A Abbass - CMAJ, 2003 - academia.edu
Iappreciated CMAJ's recent editorial on drug marketing, 1 but I wish to highlight here a major
medical education issue that is usually overlooked, in part because of the influence wielded …
medical education issue that is usually overlooked, in part because of the influence wielded …
ALEXANDER L. MILLER M. LYNN CRISMON CATHERINE S. HALL
CB BAKER - Mental Health Services: A Public Health Perspective, 2004 - books.google.com
This chapter addresses three aspects of the field of psychopharmacology that, directly or
indirectly, have a very large impact on the design and delivery of mental health services to …
indirectly, have a very large impact on the design and delivery of mental health services to …
[HTML][HTML] Isn't it about time to employ measurement-based care in practice?
AJ Rush - American Journal of Psychiatry, 2015 - Am Psychiatric Assoc
Measurement-based care is by no means novel. In fact, for decades the regular
measurement of both symptoms and side effects has been an integral component of all …
measurement of both symptoms and side effects has been an integral component of all …
Professor Robert W. Kerwin, MA, PhD, MS SChir, DSc, FRCPsych 1955-2007
D Taylor - Clinical Drug Investigation, 2007 - go.gale.com
Rob Kerwin was born in Salford, Greater Manchester, UK, in 1955. He attended local
schools where his exceptional intelligence was soon recognised and he later gained entry …
schools where his exceptional intelligence was soon recognised and he later gained entry …
Prescribing Observatory for Mental Health (2024). QI programme 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people's mental …
TRE Barnes, C Paton, G Herrington, O Rendora… - 2024 - abdn.elsevierpure.com
This report presents the results of the baseline audit for a quality improvement programme
(QIP) addressing Topic 22a: The use of medicines with anticholinergic (antimuscarinic) …
(QIP) addressing Topic 22a: The use of medicines with anticholinergic (antimuscarinic) …
[PDF][PDF] AMERICAN PSYCHIATRIC ASSOCIATION STEERING COMMITTEE ON PRACTICE GUIDELINES
J Yager, JE Nininger, TJ Craig, D Cowley, MT Finnerty… - Am Psychiatric Assoc
Note: The authors have worked to ensure that all information in these books concerning
drug dosages, schedules, and routes of administration is accurate as of the time of …
drug dosages, schedules, and routes of administration is accurate as of the time of …
TDM Journal Club
A Hamada, A Aoki, H Terazaki, K Ito… - Therapeutic Drug …, 2005 - journals.lww.com
ERRATUM : Therapeutic Drug Monitoring ERRATUM : Therapeutic Drug Monitoring Log in or
Register Subscribe to journalSubscribe Get new issue alertsGet alerts Secondary Logo Journal …
Register Subscribe to journalSubscribe Get new issue alertsGet alerts Secondary Logo Journal …
[CITATION][C] CE: Issues for Managed Care Pharmacy
DL Lindgren - American Pharmacy, 1995 - Elsevier
• As outcomes management programs become prevalent, pharmacists-particularly managed
care pharmacists-will take on more responsibility for the delivery, tracking, and analysis of …
care pharmacists-will take on more responsibility for the delivery, tracking, and analysis of …
Implementing standardized assessments in clinical care: now's the time
M Valenstein, DA Adler, J Berlant, LB Dixon… - Psychiatric …, 2009 - Am Psychiatric Assoc
Although there are likely many progenitors of the current call for measurement-based care in
clinical settings (for example, payers' concerns about value received for health care dollars …
clinical settings (for example, payers' concerns about value received for health care dollars …